Biospecimens, Research Consent, and Distinguishing Cell Line Research-Reference-Cited by-同舟云学术

Biospecimens, Research Consent, and Distinguishing Cell Line Research

Published:2019-03-01 Issue:3 Volume:5 Page:406
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Spector-Bagdady Kayte¹²,Fernandez Lynch Holly³,Brenner J. Chad²⁴,Shuman Andrew G.²⁴

Affiliation:

1. Department of Obstetrics and Gynecology, University of Michigan Medical School, Ann Arbor

2. Center for Bioethics and Social Sciences in Medicine, University of Michigan Medical School, Ann Arbor

3. Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia

4. Department of Otolaryngology–Head and Neck Surgery, University of Michigan Medical School, Ann Arbor

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

http:///jamaoncology/article-pdf/5/3/406/17345833/jamaoncology_spectorbagdady_2019_sc_180003.pdf

Reference24 articles.

1. Federal policy for the protection of human subjects.;Department of Homeland Security;Fed Regist,2018

2. Federal policy for the protection of human subjects.;Department of Homeland Security;Fed Regist,2017

3. Federal policy for the protection of human subjects.;Department of Homeland Security;Fed Regist,2015

4. Human subjects research protections: enhancing protections for research subjects and reducing burden, delay, and ambiguity for investigators.;Department of Health and Human Services;Fed Regist,2011

5. Immortal life of the Common Rule: ethics, consent, and the future of cancer research.;Smith;J Clin Oncol,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges Faced by States and the WHO in Efficiently Regulating the Use of mRNA Vaccines;IECV 2023;2023-12-01

2. Regulations and Norms for Reuse of Residual Clinical Biospecimens and Health Data;Western Journal of Nursing Research;2021-07-08

3. Governing secondary research use of health data and specimens: the inequitable distribution of regulatory burden between federally funded and industry research;Journal of Law and the Biosciences;2021-01

4. What Can We Learn About Drug Safety and Other Effects in the Era of Electronic Health Records and Big Data That We Would Not Be Able to Learn From Classic Epidemiology?;Journal of Surgical Research;2020-02